+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Mutational analyses of the extracellular domain of the full-length lutropin/choriogonadotropin receptor suggest leucine-rich repeats 1-6 are involved in hormone binding



Mutational analyses of the extracellular domain of the full-length lutropin/choriogonadotropin receptor suggest leucine-rich repeats 1-6 are involved in hormone binding



Molecular Endocrinology 10(6): 760-768



Previous studies have demonstrated that the amino-terminal extracellular domain of the lutropin/choriogonadotropin receptor (LHR) is sufficient for conferring high affinity binding and binding specificity. The present study was undertaken to further delineate those regions involved in hormone binding. Since the extracellular domains of the gonadotropin receptors are defined by multiple leucine-rich repeat motifs, LHR deletion mutants were constructed in which individual or multiple leucine-rich repeats were deleted from the full-length receptor. These mutants were transiently expressed in mammalian 293 cells, assayed for protein expression by Western blotting of cell extracts, and then tested for hormone binding in both intact cells and detergent-solubilized cell extracts. Western blot analyses confirmed the expression of all LHR deletion mutant proteins in the transfected cells. Although human (h) CG binding activity was not detected for any of the mutants when intact cells were assayed, mutants in which leucine-rich repeats 9-14 were collectively deleted, or repeats 7 or 8 were individually deleted, expressed binding activity when the cells were first solubilized in detergent. Of significance, rat (r) LHR(delta LRR 9-14) exhibited high affinity hCG and hLH binding, comparable to wild type rLHR. Detergent extracts from cells expressing rLHR(delta LRR 8) and rLHR(delta LRR 7) bound hCG and hLH, albeit with reduced affinities compared with the wild type receptor. All three of these deletion mutants, rLHR(delta LRR 9-14), rLHR(delta LRR 8), and rLHR(delta LRR 7), exhibited normal binding specificity as they did not bind hFSH even at very high concentrations. Thus, deletion of these regions in the carboxyl portion of the extracellular domain of the LHR did not remove any potentially inhibitory elements that would normally prevent hFSH binding. Deletion of either the 11 amino-terminal acids before LRR 1 or LRRs 1, 2, 3, 4, 5, or 6 individually from the full-length rLHR resulted in the total absence of detectable hCG binding activity in detergent-solubilized extracts, in spite of stable protein expression. These results suggest that the amino terminus and LRRs 1-6 are absolutely essential for gonadotropin binding to the rLHR.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 046748963

Download citation: RISBibTeXText

PMID: 8776736

DOI: 10.1210/mend.10.6.8776736


Related references

Deletions of portions of the extracellular loops of the lutropin/choriogonadotropin receptor decrease the binding affinity for ovine luteinizing hormone, but not human choriogonadotropin, by preventing the formation of mature cell surface receptor. Journal of Biological Chemistry 271(8): 4518-4527, 1996

Extracellular domain of lutropin/choriogonadotropin receptor expressed in transfected cells binds choriogonadotropin with high affinity. Journal of Biological Chemistry 265(35): 21411-4, 1990

A defined epitope on the human choriogonadotropin a-subunit interacts with the second extracellular loop of the transmembrane domain of the lutropin/choriogonadotropin receptor. European Journal of Biochemistry 241: 7-32, 1996

A defined epitope on the human choriogonadotropin alpha-subunit interacts with the second extracellular loop of the transmembrane domain of the lutropin/choriogonadotropin receptor. European Journal of Biochemistry 241(2): 627-632, 1996

The differential binding affinities of the luteinizing hormone (LH)/choriogonadotropin receptor for LH and choriogonadotropin are dictated by different extracellular domain residues. Molecular Endocrinology 19(5): 1263-1276, 2005

Identification of two amino acid residues on the extracellular domain of the lutropin/choriogonadotropin receptor important in signaling. Journal of Biological Chemistry 270(50): 30023-8, 1995

Identification of ionizable amino acid residues on the extracellular domain of the lutropin receptor involved in ligand binding. Endocrinology 140(10): 4558-4563, 1999

Ligand Selectivity of Gonadotropin Receptors: Role of the b-Strands of Extracellular Leucine-rich Repeats 3 and 6 of the Human Luteinizing Hormone Receptor. The Journal of Biological Chemistry 278(18): 505-13, 2003

High expression of the hormone binding active extracellular domain (1-294) of rat lutropin receptor in Escherichia coli. Molecular and Cellular Endocrinology 91(1-2): 35-41, 1993

Ligand selectivity of gonadotropin receptors. Role of the beta-strands of extracellular leucine-rich repeats 3 and 6 of the human luteinizing hormone receptor. Journal of Biological Chemistry 278(18): 15505-15513, 2003

Pleiotropic effects of substitutions of a highly conserved leucine in transmembrane helix III of the human lutropin/choriogonadotropin receptor with respect to constitutive activation and hormone responsiveness. Molecular Endocrinology 15(6): 972-984, 2001

LRRC8 extracellular domain is composed of 17 leucine-rich repeats. Molecular Immunology 41(5): 561-562, 2004

Thyrotropin (TSH) receptor residue E251 in the extracellular leucine-rich repeat domain is critical for linking TSH binding to receptor activation. Endocrinology 151(4): 1940-1947, 2010

Intracellular retention of mutant gonadotropin receptors results in loss of hormone binding activity of the follitropin receptor but not of the lutropin/choriogonadotropin receptor. Molecular Endocrinology 9(12): 1727-1736, 1995

Site-Directed Mutagenesis of Conserved Charged Residues in the Leucine-Rich Repeats of Platelet Glycoprotein Ibalpha Reveals a Vital Role for the Fourth and Sixth Leucine-Rich Repeats in von Willebrand Factor Binding. Blood 100(11): Abstract No 978, 2002